Matthew Siegel is vice president of medical affairs at Maine Behavioral Healthcare in Portland.
Matthew Siegel
Vice president
Maine Behavioral Healthcare
From this contributor
Autism can mask anxiety symptoms
Anxiety is one of the most common mental health conditions, as well as one of the most treatable. But when a person has autism, anxiety symptoms can be hard to see. Matthew Siegel calls for anxiety tests and treatments that are tailored to people with autism.
Searching for psychiatrists with expertise in autism
There is an urgent need for psychiatrists who are trained to care for individuals with autism. Matthew Siegel calls for a formal training program in autism for psychiatrists.
Searching for psychiatrists with expertise in autism
By
Matthew Siegel
17 October 2014 | 3 min read
Explore more from The Transmitter
The Transmitter’s most-read neuroscience book excerpts of 2025
Books by Nachum Ulanovsky, Nicole Rust, and Andrew Iwaniuk and Georg Striedter made the list of some of the year's most engaging neuroscience titles.
The Transmitter’s most-read neuroscience book excerpts of 2025
Books by Nachum Ulanovsky, Nicole Rust, and Andrew Iwaniuk and Georg Striedter made the list of some of the year's most engaging neuroscience titles.
By
The Transmitter
24 December 2025 | 2 min read
Neuroscience’s leaders, legacies and rising stars of 2025
Here are seven stories from the past year about some of the field’s most engaging figures.
Neuroscience’s leaders, legacies and rising stars of 2025
Here are seven stories from the past year about some of the field’s most engaging figures.
By
The Transmitter
24 December 2025 | 2 min read
The Transmitter’s top news articles of 2025
Check out some of our most-read stories, covering neuroscience funding and policy changes in the United States, and methodological issues in high-profile neuroscience papers.
The Transmitter’s top news articles of 2025
Check out some of our most-read stories, covering neuroscience funding and policy changes in the United States, and methodological issues in high-profile neuroscience papers.
By
The Transmitter
24 December 2025 | 3 min read